Status:
RECRUITING
Brain Vascular and Neural Function Linked to Balance Across the Adult Lifespan
Lead Sponsor:
University of Minnesota
Conditions:
Neurotypical
Cognitively Normal
Eligibility:
All Genders
21-95 years
Phase:
NA
Brief Summary
This is a single-arm, two-visit, non-randomized, cross sectional study identified as an intervention due to the use of a single bout of aerobic exercise to assess cerebrovascular function under the NI...
Eligibility Criteria
Inclusion
- Age within the following 3 group age ranges, 21-30yo; middle-aged: 40-55yo; older: 65-95yo adults
- the absence of major orthopedic disability
- cognitively normal (MoCA score ≥ 26/30 in older adult group)
- vision that is 20/40 or better with or without corrective lenses, (5) the ability to consent and communicate with researchers
- English speaking
- ability to stand for 3 minutes and walk 10 meters with or without an assistive device and without the assistance of another person.
Exclusion
- insulin-dependent diabetes
- peripheral neuropathy
- myocardial infarction or symptoms of coronary artery disease within 2 years
- congestive heart failure or class IV heart failure
- any significant sensory impairment affecting balance or cognition; visual, vestibular, or auditory impairments.
Key Trial Info
Start Date :
October 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2028
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06127667
Start Date
October 15 2024
End Date
July 1 2028
Last Update
October 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55414